BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22798154)

  • 21. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    De Felice F; Magnante AL; Musio D; Ciolina M; De Cecco CN; Rengo M; Laghi A; Tombolini V
    Eur J Surg Oncol; 2017 Jul; 43(7):1324-1329. PubMed ID: 28363512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
    Intven M; Monninkhof EM; Reerink O; Philippens ME
    Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma.
    Chidambaram V; Brierley JD; Cummings B; Bhayana R; Menezes RJ; Kennedy ED; Kirsch R; Jhaveri KS
    Abdom Radiol (NY); 2017 May; 42(5):1310-1318. PubMed ID: 28004138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.
    Jang KM; Kim SH; Choi D; Lee SJ; Park MJ; Min K
    Br J Radiol; 2012 Sep; 85(1017):e566-72. PubMed ID: 22422387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cai PQ; Wu YP; An X; Qiu X; Kong LH; Liu GC; Xie CM; Pan ZZ; Wu PH; Ding PR
    Eur Radiol; 2014 Nov; 24(11):2962-70. PubMed ID: 25038851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of diffusion-weighted magnetic resonance imaging in prediction of the response to preoperative chemoradiotherapy in rectal carcinoma].
    Liang X; Zhang HM; Ye F; Ouyang H; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):133-7. PubMed ID: 26899334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeatability of diffusion-weighted imaging in rectal cancer.
    Intven M; Reerink O; Philippens ME
    J Magn Reson Imaging; 2014 Jul; 40(1):146-50. PubMed ID: 24127172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
    Cai G; Xu Y; Zhu J; Gu WL; Zhang S; Ma XJ; Cai SJ; Zhang Z
    World J Gastroenterol; 2013 Sep; 19(33):5520-7. PubMed ID: 24023496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
    Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
    J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Sathyakumar K; Chandramohan A; Masih D; Jesudasan MR; Pulimood A; Eapen A
    Br J Radiol; 2016; 89(1060):20150328. PubMed ID: 26828967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent diffusion coefficient for lymph node characterization after chemoradiation therapy for locally advanced rectal cancer.
    Kim SH; Ryu KH; Yoon JH; Lee Y; Paik JH; Kim SJ; Jung HK; Lee KH
    Acta Radiol; 2015 Dec; 56(12):1446-53. PubMed ID: 25425724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.
    Sun YS; Zhang XP; Tang L; Ji JF; Gu J; Cai Y; Zhang XY
    Radiology; 2010 Jan; 254(1):170-8. PubMed ID: 20019139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance of Rectal Cancer Response to Therapy: An Image Quality Comparison between 3.0 and 1.5 Tesla.
    Caruso D; Zerunian M; De Santis D; Biondi T; Paolantonio P; Rengo M; Bellini D; Ferrari R; Ciolina M; Lucertini E; Polici M; Iannicelli E; Tombolini V; Laghi A
    Biomed Res Int; 2020; 2020():9842732. PubMed ID: 33102603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
    Blazic IM; Lilic GB; Gajic MM
    Radiology; 2017 Feb; 282(2):418-428. PubMed ID: 27253423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.